Notably, PTEN loss in tumor cells causes upregulated immunosuppressive cytokines and chemokines, leading to exclusion of CD8 T cells and enrichment of Tregs in the tumor, ultimately rendering anti–PD-1 therapy ineffective [32,33,34]. Here, PDCD1 is linked to neoplasm.